Back
Amicus Therapeutics Quote, Financials, Valuation and Earnings
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
25
FOLD
Amicus Therapeutics
Last Price:
10.28
Seasonality Move:
21.11%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeAmicus Therapeutics Price Quote
$10.28
Amicus Therapeutics Key Stats
Sell
25
Amicus Therapeutics (FOLD)
is a Sell
Day range:
$10.11 - $10.32
52-week range:
$9.70 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.60
P/B ratio:
18.96%
Volume:
1.7M
Avg. volume:
2.7M
1-year change:
-11.07%
Market cap:
$3B
Revenue:
$399.4M
EPS:
$-0.51
How Much Does Amicus Therapeutics Make?
-
How Much Are Amicus Therapeutics's Sales Annually?
FOLD Revenues are $399.4M -
How Much Profit Does Amicus Therapeutics's Make A Year?
FOLD net income is -$151.6M
Is Amicus Therapeutics Growing As A Company?
-
What Is Amicus Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.31% -
What Is Amicus Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Amicus Therapeutics Stock Price Performance
-
Did Amicus Therapeutics Stock Go Up Last Month?
Amicus Therapeutics share price went down by -10.06% last month -
Did FOLD's Share Price Rise Over The Last Year?
FOLD share price fell by -11.07% over the past 1 year
What Is Amicus Therapeutics 52-Week High & Low?
-
What Is Amicus Therapeutics’s 52-Week High Share Price?
Amicus Therapeutics has traded as high as $14.57 over the past 52 weeks -
What Is Amicus Therapeutics’s 52-Week Low Share Price?
Amicus Therapeutics has traded as low as $9.70 over the past 52 weeks
Amicus Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Amicus Therapeutics?
-
How Much Debt Does Amicus Therapeutics Have?
Total long term debt quarterly is $387.9M -
How Much Cash Does Amicus Therapeutics Have?
Cash and short term investments quarterly total is $286.2M -
What Is Amicus Therapeutics’s Book Value Per Share?
Book value per share is 0.55
Is Amicus Therapeutics Cash Flow Positive?
-
What Is FOLD Cash Flow From Operations?
Cash flow from operations (TTM) is -$69.1M -
What Is Amicus Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $61.7M -
What Is Amicus Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $98.1M
Amicus Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FOLD return on invested capital is -29.26% -
What Is Amicus Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -20.5% -
What Is FOLD Return On Equity?
ROE is a measure of profitability and is -120.19%
Amicus Therapeutics Earnings Date & Stock Price
-
What Is Amicus Therapeutics's Stock Price Today?
A single share of FOLD can be purchased today for 10.28 -
What Is Amicus Therapeutics’s Stock Symbol?
Amicus Therapeutics trades on the nasdaq under the ticker symbol: FOLD -
When Is Amicus Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Amicus Therapeutics is scheduled on May 10, 2024 -
When Is FOLD's next ex-dividend date?
Amicus Therapeutics's next ex-dividend date is May 1, 2020 -
How To Buy Amicus Therapeutics Stock?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amicus Therapeutics Competitors
-
Who Are Amicus Therapeutics's Competitors?
Below is a list of companies who compete with Amicus Therapeutics or are related in some way:
Amicus Therapeutics Dividend Yield
Data Unavailable
Amicus Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 126.82% |
| Revenue: | 30.63% | 0.03% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 18.78 |
| Upside from Last Price: | 82.66% |